Toward a Molecular Equivalent Dose: Use of the Medaka Model in Comparative Risk Assessment

Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology - United States
doi 10.1016/j.cbpc.2008.07.013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Appropriate Use of Effective Dose in Radiation Protection and Risk Assessment

Health Physics
Nuclear MedicineRadiologyMutagenesisEpidemiologyHealthImagingToxicology
2017English

Neutron Dose Equivalent in Tissue Due to Linacs of Clinical Use

2013English

Verification of an Effective Dose Equivalent Model for Neutrons

Radiation Protection Dosimetry
Nuclear MedicineRadiologyUltrasound TechnologyPublic HealthRadiationEnvironmentalRadiologicalImagingMedicineOccupational Health
1992English

Use of Molecular Mutations in High Risk MPN for Assessment of Blastic Transformation

Pathology
Forensic MedicinePathology
2020English

Toward a Contingency Model of Strategic Risk Taking.

Academy of Management Review
ManagementBusinessStrategyInnovationAccountingManagement of Technology
1985English

Outcome of a Public Consultation on the Draft Update of the Guidance on the Use of the Benchmark Dose Approach in Risk Assessment

EFSA Supporting Publications
2017English

Toward an Understanding of the Molecular Mechanisms of Barnacle Larval Settlement: A Comparative Transcriptomic Approach

PLoS ONE
Multidisciplinary
2011English

Risk Assessment Methodology in the Use of Mobile Phones

2015English

Assessment of the Potential Risk Factors of Prostate Cancer: A Comparative Study

IOSR Journal of Mathematics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy